Results 251 to 260 of about 452,650 (302)
Some of the next articles are maybe not open access.
New antibiotics for skin and skin-structure infections
The Lancet Infectious Diseases, 2014Comment on Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial. [Lancet Infect Dis. 2014]
Tacconelli, Evelina, Kern, Winfried V
openaire +4 more sources
Bacterial Infections of Skin and Skin Structures
2020A 12-year-old female was evaluated in the emergency department (ED) for a swelling on her right leg. She is previously healthy; however, she has several mosquito bites on her leg which she has been scratching. Over the past 12 hours, she has had worsening redness and swelling around one of the mosquito bites, with associated fevers and vomiting. In the
Joseph Domachowske, Manika Suryadevara
openaire +1 more source
Novel antibacterial agents for skin and skin structure infections
Journal of the American Academy of Dermatology, 2004With the continuing development of clinical drug resistance among bacteria and the advent of resistance to the recently released agents quinupristin-dalfopristin and linezolid, the need for new, effective agents to treat multidrug-resistant gram-positive infections remains important.
Eric S, Schweiger, Jeffrey M, Weinberg
openaire +2 more sources
Fluoroquinolone Treatment of Skin and Skin Structure Infections
Drugs, 1999When the causative pathogens are susceptible, the fluoroquinolones have been demonstrated to be highly efficacious in the treatment of both mild uncomplicated skin and skin structure infections as well as the more severe complicated infections involving these tissues, including infections of the feet of diabetic patients.
openaire +2 more sources
Optimum Outpatient Therapy of Skin and Skin Structure Infections
Drugs, 1994Skin and skin structure infections appear in a variety of ways with multiple aetiologies. Optimum therapy is accomplished with a good understanding of both skin anatomy and common resident or transient bacterial flora present on the skin surface. Primary and secondary infections occur in both immunocompetent and immunocompromised patients, each of ...
D M, Failla, G A, Pankey
openaire +2 more sources
Treatment of bacterial skin and skin structure infections
Expert Opinion on Pharmacotherapy, 2003Bacterial skin and skin structure infections (SSSIs) are among the most frequently seen infectious entities in the community setting and occasionally in the institutional setting. A wide variety of SSSIs exist, with cellulitis, impetigo and folliculitis being the most common. Most SSSIs are caused by aerobic staphylococci and streptococci, with aerobic
openaire +2 more sources
Emerging drugs for complicated skin and skin-structure infections
Expert Opinion on Emerging Drugs, 2010IMPORTANCE OF THE FILED: With the worldwide surge of MRSA, skin and skin-structure infection (SSTI) treatment has become a challenge for physicians. Cultures and antibiotic susceptibility tests for SSTIs are the rule due to the implication in morbidity and mortality rates associated with MRSA infections.
Natalia, Mendoza, Stephen K, Tyring
openaire +2 more sources
Antibiotic treatment of acute bacterial skin and skin structure infections
Current Opinion in Infectious Diseases, 2022Purpose of review Acute bacterial skin and skin structure infections (ABSSSI) are a leading cause of morbidity, with a considerable variety of clinical presentation and a wide range of etiological pathogens. Of importance, the spread of multidrug-resistant (MDR) strains (i.e.
Russo, Alessandro +2 more
openaire +3 more sources
Skin and Skin Structure Infections in Older Adults
Current Geriatrics Reports, 2014The aging population undergoes anatomical, physiological, and environmental changes, which puts them at increased risk for skin and skin structure infections. Skin and skin structure infections in older adults can range from simple cellulitis to life-threatening necrotizing fasciitis.
Jisha John, Kyle Miletic, Keith S. Kaye
openaire +1 more source
Managing acute bacterial skin and skin structure infections
The Nurse Practitioner, 2017Abstract: Acute bacterial skin and skin structure infections (ABSSSI) are some of the most commonly encountered infections worldwide. Hospitalizations as a result of ABSSSI are associated with high mortality. This article discusses the role of oritavancin and dalbavancin, two new lipoglycopeptides, in the context of the other I.
Allison M, Bell +5 more
openaire +2 more sources